SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - (GEM) PRINTED: 19/02/03 PAGE: 1
DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
(GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)
STOCK NAME : Sino Biopharm (08027)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
WANG JIN YU G ORD SINO BIOPHARMACEUTICAL LIMITED 300,000 020104-010107 0.740 1
G ORD SINO BIOPHARMACEUTICAL LIMITED 300,000 020105-010107 0.740 1
LING PEIXUE G ORD SINO BIOPHARMACEUTICAL LIMITED 300,000 020104-010107 0.740 1
G ORD SINO BIOPHARMACEUTICAL LIMITED 300,000 020105-010107 0.740 1
STOCK NAME : VC Holdings (08101)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
KO CHUN FUNG HENRY G ORD VALUE CONVERGENCE HOLDINGS LIM- 31,365,103 0.360 1 N2
ITED
CHENG KAR SHING PETER G ORD VALUE CONVERGENCE HOLDINGS LIM- 7,350,000 0.360 1 N2
ITED
LEE JUN SING G ORD VALUE CONVERGENCE HOLDINGS LIM- 31,365,103 0.360 1 N2
ITED
HO YAU LUNG LAWRENCE G ORD VALUE CONVERGENCE HOLDINGS LIM- 7,350,000 0.360 1 N2
ITED
HO HUNG SUN STANLEY G ORD VALUE CONVERGENCE HOLDINGS LIM- 7,350,000 0.360 1 N2
ITED
***** END OF REPORT *****
NOTES
N1 30,000 shares were transferred to employees pursuant to the Share
Option Scheme at HK$0.0138 per share.
N2 The number of securities & exercise price have been adjusted as a
result of rights issue.
|